Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Journal of Biological Engineering
|
October 30, 2025
Advancements in zinc oxide nanofibers for enhanced rehabilitation and injury recovery: mechanisms, applications, and future directions
Lingzhi Hong, Nannan Zhou
Contrast Media & Molecular Imaging
|
December 15, 2021
Application of Artificial Intelligence in Emergency Nursing of Patients with Chronic Obstructive Pulmonary Disease
Lingzhi Hong, Xufang Cheng, Deming Zheng
Cancers
|
February 11, 2023
MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities
Kang Qin, Lingzhi Hong, Jianjun Zhang, et al.
Therapeutic Advances in Medical Oncology
|
March 1, 2021
Current and future treatment options for <i>MET</i> exon 14 skipping alterations in non-small cell lung cancer
Lingzhi Hong, Jianjun Zhang, John V Heymach, et al.
Oncology Reports
|
July 30, 2009
The expression of high-mobility group protein box 1 correlates with the progression of non-small cell lung cancer
Xiaokun Shen, Lingzhi Hong, Huiming Sun, et al.
Molecular Biology Reports
|
August 19, 2009
Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human lung adenocarcinoma cell line (A549) in vitro
Lingzhi Hong, Huiming Sun, Xiaojing Lv, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 3, 2007
Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer
Yucai Wang, Zhenghong Yu, Tingting Wang, et al.
Oncology Letters
|
July 17, 2018
Hint1 expression inhibits proliferation and promotes radiosensitivity of human SGC7901 gastric cancer cells
Xiaowei Wei, Jin Zhou, Lingzhi Hong, et al.
JTO Clinical and Research Reports
|
November 25, 2021
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With <i>EGFR</i> or <i>ALK</i> Alterations
Whitney E Lewis, Lingzhi Hong, Frank E Mott, et al.
NPJ Precision Oncology
|
October 1, 2024
Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients
Lingzhi Hong, Sonia Patel, Leylah M Drusbosky, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Journal of Biological Engineering
|
October 30, 2025
Advancements in zinc oxide nanofibers for enhanced rehabilitation and injury recovery: mechanisms, applications, and future directions
Lingzhi Hong, Nannan Zhou
Contrast Media & Molecular Imaging
|
December 15, 2021
Application of Artificial Intelligence in Emergency Nursing of Patients with Chronic Obstructive Pulmonary Disease
Lingzhi Hong, Xufang Cheng, Deming Zheng
Cancers
|
February 11, 2023
MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities
Kang Qin, Lingzhi Hong, Jianjun Zhang, et al.
Therapeutic Advances in Medical Oncology
|
March 1, 2021
Current and future treatment options for <i>MET</i> exon 14 skipping alterations in non-small cell lung cancer
Lingzhi Hong, Jianjun Zhang, John V Heymach, et al.
Oncology Reports
|
July 30, 2009
The expression of high-mobility group protein box 1 correlates with the progression of non-small cell lung cancer
Xiaokun Shen, Lingzhi Hong, Huiming Sun, et al.
Molecular Biology Reports
|
August 19, 2009
Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human lung adenocarcinoma cell line (A549) in vitro
Lingzhi Hong, Huiming Sun, Xiaojing Lv, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 3, 2007
Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer
Yucai Wang, Zhenghong Yu, Tingting Wang, et al.
Oncology Letters
|
July 17, 2018
Hint1 expression inhibits proliferation and promotes radiosensitivity of human SGC7901 gastric cancer cells
Xiaowei Wei, Jin Zhou, Lingzhi Hong, et al.
JTO Clinical and Research Reports
|
November 25, 2021
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With <i>EGFR</i> or <i>ALK</i> Alterations
Whitney E Lewis, Lingzhi Hong, Frank E Mott, et al.
NPJ Precision Oncology
|
October 1, 2024
Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients
Lingzhi Hong, Sonia Patel, Leylah M Drusbosky, et al.
Page
of 6